Reata Pharmaceuticals logo
Reata Pharmaceuticals RETA

Quarterly report 2023-Q1
added 05-10-2023

report update icon

Reata Pharmaceuticals P/S Ratio 2011-2026 | RETA

Annual P/S Ratio Reata Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
742 88.9 387 223 39.8 14.4 9.93 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
742 9.93 215

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
172 - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.73 $ 19.14 0.74 % $ 895 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
2.24 $ 14.74 -0.2 % $ 216 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.63 3.5 % $ 434 M britainBritain
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
BioNTech SE BioNTech SE
BNTX
35.7 $ 94.9 0.82 % $ 22.9 B germanyGermany
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
1.39 $ 3.13 -0.48 % $ 651 M usaUSA
Exelixis Exelixis
EXEL
5.05 $ 49.35 2.47 % $ 13.4 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
1.23 $ 2.36 -1.26 % $ 65.8 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
181 $ 24.9 3.65 % $ 322 M usaUSA
AbbVie AbbVie
ABBV
24.1 $ 203.32 0.97 % $ 360 B usaUSA
Gilead Sciences Gilead Sciences
GILD
6.23 $ 133.2 1.42 % $ 166 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Compugen Ltd. Compugen Ltd.
CGEN
49.8 $ 2.82 -2.76 % $ 263 M israelIsrael
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.33 $ 22.41 0.04 % $ 3.71 B usaUSA
Genmab A/S Genmab A/S
GMAB
15.6 $ 26.36 -0.26 % $ 1.71 B danmarkDanmark
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 3.46 -1.98 % $ 5.7 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
1.54 - 5.93 % $ 314 M canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
0.627 $ 8.05 -0.62 % $ 5.47 B spainSpain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
13.3 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
9.15 $ 21.09 -0.4 % $ 2.68 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
106 - -11.43 % $ 502 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
54.1 - - $ 8.42 M usaUSA